183 related articles for article (PubMed ID: 35737038)
1. Correlation Investigation between Pyrrole-DNA and Pyrrole-Protein Adducts in Male ICR Mice Exposed to Retrorsine, a Hepatotoxic Pyrrolizidine Alkaloid.
Zhu L; Xue J; He Y; Xia Q; Fu PP; Lin G
Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737038
[TBL] [Abstract][Full Text] [Related]
2. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.
Ma J; Li M; Li N; Chan WY; Lin G
Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679016
[TBL] [Abstract][Full Text] [Related]
3. The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity.
Lu Y; Ma J; Song Z; Ye Y; Fu PP; Lin G
Arch Toxicol; 2018 Nov; 92(11):3403-3414. PubMed ID: 30244272
[TBL] [Abstract][Full Text] [Related]
4. Pyrrole-protein adducts - A biomarker of pyrrolizidine alkaloid-induced hepatotoxicity.
Ma J; Xia Q; Fu PP; Lin G
J Food Drug Anal; 2018 Jul; 26(3):965-972. PubMed ID: 29976414
[TBL] [Abstract][Full Text] [Related]
5. 7-Glutathione-pyrrole and 7-cysteine-pyrrole are potential carcinogenic metabolites of pyrrolizidine alkaloids.
He X; Xia Q; Fu PP
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2017 Apr; 35(2):69-83. PubMed ID: 28418776
[TBL] [Abstract][Full Text] [Related]
6. Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human.
Zhu L; Zhang C; Zhang W; Xia Q; Ma J; He X; He Y; Fu PP; Jia W; Zhuge Y; Lin G
Arch Toxicol; 2021 Oct; 95(10):3191-3204. PubMed ID: 34390356
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
Wang YP; Fu PP; Chou MW
Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
[TBL] [Abstract][Full Text] [Related]
8. The long persistence of pyrrolizidine alkaloid-derived DNA adducts in vivo: kinetic study following single and multiple exposures in male ICR mice.
Zhu L; Xue J; Xia Q; Fu PP; Lin G
Arch Toxicol; 2017 Feb; 91(2):949-965. PubMed ID: 27125825
[TBL] [Abstract][Full Text] [Related]
9. Pyrrolizidine alkaloid-derived DNA adducts are common toxicological biomarkers of pyrrolizidine alkaloid N-oxides.
He X; Xia Q; Woodling K; Lin G; Fu PP
J Food Drug Anal; 2017 Oct; 25(4):984-991. PubMed ID: 28987376
[TBL] [Abstract][Full Text] [Related]
10. Primary and secondary pyrrolic metabolites of pyrrolizidine alkaloids form DNA adducts in human A549 cells.
He X; Xia Q; Wu Q; Tolleson WH; Lin G; Fu PP
Toxicol In Vitro; 2019 Feb; 54():286-294. PubMed ID: 30366057
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids.
Song Z; He Y; Ma J; Fu PP; Lin G
J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolizidine Alkaloid Secondary Pyrrolic Metabolites Construct Multiple Activation Pathways Leading to DNA Adduct Formation and Potential Liver Tumor Initiation.
Xia Q; He X; Ma L; Chen S; Fu PP
Chem Res Toxicol; 2018 Jul; 31(7):619-628. PubMed ID: 29855181
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity.
Xia Q; Zhao Y; Von Tungeln LS; Doerge DR; Lin G; Cai L; Fu PP
Chem Res Toxicol; 2013 Sep; 26(9):1384-96. PubMed ID: 23937665
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
Yang M; Ruan J; Fu PP; Lin G
Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
[TBL] [Abstract][Full Text] [Related]
15. Antibody-based detection of lysine modification of hepatic protein in mice treated with retrorsine.
Cheng T; Li W; Yang X; Wang H; Zhang F; Li N; Lin G; Zheng J
J Environ Sci Health C Toxicol Carcinog; 2020; 38(4):315-328. PubMed ID: 33382013
[TBL] [Abstract][Full Text] [Related]
16. 1-Formyl-7-hydroxy-6,7-dihydro-5 H-pyrrolizine (1-CHO-DHP): A Potential Proximate Carcinogenic Metabolite of Pyrrolizidine Alkaloids.
He X; Xia Q; Gamboa da Costa G; Lin G; Fu PP
Chem Res Toxicol; 2019 Jun; 32(6):1193-1203. PubMed ID: 31120748
[TBL] [Abstract][Full Text] [Related]
17. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
[TBL] [Abstract][Full Text] [Related]
18. The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica.
Chen Y; Xiong F; Wang W; Jiang K; Ye X; Deng G; Wang C; Yang L; Xiong A; Wang Z
Toxicol Lett; 2020 May; 323():41-47. PubMed ID: 31982501
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans.
Ma J; Zhang W; He Y; Zhu L; Zhang C; Liu J; Ye Y; Zhuge Y; Lin G
Arch Toxicol; 2021 Feb; 95(2):759-765. PubMed ID: 33210216
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis.
Ruan J; Yang M; Fu P; Ye Y; Lin G
Chem Res Toxicol; 2014 Jun; 27(6):1030-9. PubMed ID: 24836403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
